|
LOC100129550 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.77236045021345E-15 |
| Normal-vs-Stage2 |
6.20849999966033E-07 |
| Normal-vs-Stage3 |
3.84510201456578E-11 |
| Normal-vs-Stage4 |
4.60043114713926E-12 |
| Stage1-vs-Stage2 |
2.739200E-01 |
| Stage1-vs-Stage3 |
9.954400E-01 |
| Stage1-vs-Stage4 |
1.008620E-01 |
| Stage2-vs-Stage3 |
3.334400E-01 |
| Stage2-vs-Stage4 |
2.594300E-02 |
| Stage3-vs-Stage4 |
1.441010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.99200722162641E-16 |
| Normal-vs-AfricanAmerican |
1.761820E-04 |
| Normal-vs-Asian |
5.76005909636024E-12 |
| Caucasian-vs-AfricanAmerican |
2.689400E-01 |
| Caucasian-vs-Asian |
2.208800E-01 |
| AfricanAmerican-vs-Asian |
1.072230E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.23119994596988E-09 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
2.831800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62614366416847E-12 |
| Normal-vs-Age(41-60Yrs) |
2.06090700061168E-12 |
| Normal-vs-Age(61-80Yrs) |
2.55749976751929E-10 |
| Normal-vs-Age(81-100Yrs) |
4.602400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.950200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.600400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.816600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.896800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.557800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.214200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.922200E-03 |
| Classical-VS-Follicular |
8.528400E-01 |
| Classical-VS-Other |
1.231150E-01 |
| Classical-VS-Normal |
1.64290803184031E-12 |
| Tall-VS-Follicular |
1.889800E-02 |
| Tall-VS-Other |
8.770800E-01 |
| Tall-VS-Normal |
1.35599975692458E-10 |
| Follicular-VS-Other |
2.201200E-01 |
| Follicular-VS-Normal |
5.93479998478585E-09 |
| Other-VS-Normal |
1.550010E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.42534897615587E-13 |
| Normal-vs-N1 |
9.61453139325386E-14 |
| N0-vs-N1 |
6.963300E-03 |
|
|
